Mass. gets nearly $4.7M in drug settlement

The Massachusetts attorney general's office says Pennsylvania drug maker Cephalon Inc. has agreed to a nearly $4.7 million payment to settle allegations of off-label marketing of three pharmaceutical products.

Under the terms of the settlement, the money will be paid to the Massachusetts Medicaid Program, also known as MassHealth, which provides health care products and services to low-income residents and those with disabilities.

The settlement resolves allegations that Cephalon engaged in improper off-label marketing of the drugs Actiq, a highly addictive painkiller; the anti-epilepsy drug Gabitril; and the narcolepsy drug Provigil.

The money is part of a $248 million national settlement. (AP)